Brief: Phio Pharmaceuticals Reports First Quarter 2023 Financial Results And Provides Business Update
11/05/2023 22:30
Phio Pharmaceuticals Corp PHIO.O :
* PHIO PHARMACEUTICALS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* PHIO PHARMACEUTICALS CORP - AT MARCH 31, 2023, COMPANY HAD
CASH
OF $9.0 MILLION AS COMPARED WITH $11.8 MILLION AT DECEMBER 31,
2022
* PHIO PHARMACEUTICALS CORP - EXPECTS CURRENT CASH WILL BE
SUFFICIENT TO FUND CURRENTLY PLANNED OPERATIONS INTO Q1 OF 2024
* PHIO PHARMACEUTICALS CORP - QTRLY NET LOSS INCREASED 36%
TO
APPROXIMATELY $3.6 MILLION, OR $3.15 PER SHARE
Source text for Eikon: ID:nPnbDR96Ta
Further company coverage: PHIO.O
Recent news on Phio Pharmaceuticals
See all newsPhio Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing